Atrys has consolidated its growth in the first nine months of the year, with a 9.7% increase in revenue and an 18.5% rise in EBITDA
Atrys Health, a medical company specialising in the provision of healthcare services in oncology, telediagnostics, pathological anatomy and nuclear medicine, closed the first nine months of 2026 with…